Arielle N B Kauvar1, Christopher J Arpey, George Hruza, Suzanne M Olbricht, Richard Bennett, Bassel H Mahmoud. 1. *New York University School of Medicine, New York, New York; †New York Laser & Skin Care, New York, New York; ‡Mayo Clinic, Rochester, Minnesota; §St. Louis University, St Louis, Missouri; ‖Laser & Dermatologic Surgery Center, Chesterfield, Missouri; ¶Lahey Clinic; Associate Professor, Harvard Medical School, Boston, Massachusetts; #David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; **Keck School of Medicine, University of Southern California, Los Angeles, California.
Abstract
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in the United States. Cutaneous squamous cell carcinoma has an estimated incidence of more than 700,000 new cases per year and a 5% risk of metastasis. OBJECTIVE: To provide clinicians with guidelines for the management of cSCC based on evidence from a comprehensive literature review and consensus among the authors. MATERIALS AND METHODS: The authors conducted an extensive review of the medical literature on treatment methods for cSCC, taking into consideration cure rates, recurrence and metastatic rates, aesthetic and functional outcomes, and cost effectiveness of the procedures. RESULTS: Surgical treatments provide the best outcomes for cSCC. Mohs micrographic surgery is a cost-effective procedure that affords the highest cure rate, maximal tissue preservation, and superior cosmetic outcomes. Nonsurgical methods may be used as a primary treatment for low-risk squamous cell carcinomas, but the cure rates are lower. CONCLUSION: The cure rate remains the most important consideration in choosing the treatment method, but additional factors, such as the patient's general medical condition, psychosocial circumstances, the location of the tumor and cost effectiveness of the therapy should be considered. Mohs micrographic surgery remains the preferred treatment for high-risk tumors and tumors located in cosmetically sensitive areas.
BACKGROUND:Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in the United States. Cutaneous squamous cell carcinoma has an estimated incidence of more than 700,000 new cases per year and a 5% risk of metastasis. OBJECTIVE: To provide clinicians with guidelines for the management of cSCC based on evidence from a comprehensive literature review and consensus among the authors. MATERIALS AND METHODS: The authors conducted an extensive review of the medical literature on treatment methods for cSCC, taking into consideration cure rates, recurrence and metastatic rates, aesthetic and functional outcomes, and cost effectiveness of the procedures. RESULTS: Surgical treatments provide the best outcomes for cSCC. Mohs micrographic surgery is a cost-effective procedure that affords the highest cure rate, maximal tissue preservation, and superior cosmetic outcomes. Nonsurgical methods may be used as a primary treatment for low-risk squamous cell carcinomas, but the cure rates are lower. CONCLUSION: The cure rate remains the most important consideration in choosing the treatment method, but additional factors, such as the patient's general medical condition, psychosocial circumstances, the location of the tumor and cost effectiveness of the therapy should be considered. Mohs micrographic surgery remains the preferred treatment for high-risk tumors and tumors located in cosmetically sensitive areas.
Authors: Zhong Chen; Carter Van Waes; Xin Xin Quan; Nga Voong Hawk; Weiping Chen; Jamie Coupar; Steven K Lee; David W Petersen; Paul S Meltzer; Andrew Montemarano; Martin Braun Journal: Mol Cancer Ther Date: 2018-06-29 Impact factor: 6.261
Authors: Ingrid Roscher; Ragnhild S Falk; Linda Vos; Ole P F Clausen; Per Helsing; Petter Gjersvik; Trude E Robsahm Journal: JAMA Dermatol Date: 2018-04-01 Impact factor: 10.282
Authors: Jamie K Hu; Hee-Won Suh; Munibah Qureshi; Julia M Lewis; Sharon Yaqoob; Zoe M Moscato; Sofia Griff; Alison K Lee; Emily S Yin; W Mark Saltzman; Michael Girardi Journal: Proc Natl Acad Sci U S A Date: 2021-02-16 Impact factor: 11.205
Authors: Paul R Massey; Sameer Gupta; Brooke E Rothstein; Nellie Konnikov; Meera Mahalingam; Emily S Ruiz; Chrysalyne D Schmults; Abigail Waldman Journal: Ann Surg Oncol Date: 2021-03-19 Impact factor: 5.344
Authors: Samantha Tam; Christopher M K L Yao; Moran Amit; Mona Gajera; Xiaoning Luo; Rachel Treistman; Anshu Khanna; Mohamed Aashiq; Priyadharsini Nagarajan; Diana Bell; Adel El-Naggar; Michael Migden; Michael Wong; Bonnie Glisson; Renata Ferrarotto; Bita Esmaeli; David Rosenthal; Guojun Li; Randal S Weber; Jeffrey N Myers; Neil D Gross Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-02-01 Impact factor: 6.223
Authors: Yiqiao Liu; Ethan Walker; Sukanya Raj Iyer; Mark Biro; InYoung Kim; Bo Zhou; Brian Straight; Matthew Bogyo; James P Basilion; Daniel L Popkin; David L Wilson Journal: J Med Imaging (Bellingham) Date: 2019-03-18
Authors: Flora Yan; Brittny N Tillman; Rajiv I Nijhawan; Divya Srivastava; David J Sher; Vladimir Avkshtol; Jade Homsi; Justin A Bishop; Erin M Wynings; Rebecca Lee; Larry L Myers; Andrew T Day Journal: Ann Surg Oncol Date: 2021-06-30 Impact factor: 5.344